Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GRCE

Grace Therapeutics, Inc.

CIK 0001444192 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.20
↑ 0.06 (2.80%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$46.28M
P/E Ratio
-2.29
EPS
-0.47
Dividend Yield
Not covered
52W Position
12%
Beta
0.79

Valuation multiples

Fwd P/E
2.17
PEG
Not covered
P/B
0.96
P/S
Not covered
EV/Revenue
Not covered
ROE
-41.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 12%
$1.79$5.18

Latest Financials

2026-03-31 FY
Revenue
–
Net Income
-$7.79M
Total Assets
$66.65M
Free Cash Flow
–

Recent news